Development of a novel anti-cancer agent, Sulforadex. Now in Phase I, it is initially being developed for prostate and breast cancer.
Only investors on Gust who have been granted access can view this content.
Interested in this startup? Sign In or Sign Up to request more information.
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.
Get Started for Free